Skilled Experts at a Fraction of Big Firm Rates
Our Biotech and Life Sciences Lawyers Help Clients Leverage Cutting Edge Research + Technology
Biotech Lawyer s + Life Sciences Attorney s to Help You Grow
Why Choose Amplify?
/ Experience
Our biotech lawyers have experience across the industry in structuring all types of biotech, health care and life sciences transactions. We excel at helping companies create, protect and leverage assets and R&D to grow their businesses and revenue.
/ Low Fees
Amplify provides big firm expertise and service without the big firm price tag. We believe in providing cost-effective services and strive to work on flat fee or alternative billing models whenever possible. You can have your cake and eat it too with us!
/ Value Add
We believe in pro-actively adding value in any legal matter we touch. We are focused on helping clients understand risk, grow their assets and revenue and break through in a competitive landscape. We strive to help businesses succeed.
/ Trust
We value our clients and strive to create long-term partnerships where we are trusted legal advisors. Our clients trust us with their critical life sciences legal matters and we reciprocate with dedicated.and passionate counseling.
Deep Biotech Practice Area Expertise
Licensing
We have deep experience in the in-licensing and out-licensing of IP, biotech assets and other proprietary technologies.
University Licensing
University licensing can make or break product pipelines and margins, we leverage our expertise to help clients get the best deals possible.
Genomics
We have specific experience in working with clients engaged in biological and cellular research and related culturing, genomics and bioinformatics work.
Sponsored Research
Clients rely on Amplify to negotiate sponsored research agreements with universities to protect deliverables and minimize risk.
Big Pharma
We have representated Big Pharma as well as the suppliers and partners that work with industry - creating valuable collaborations and relationships.
CROs
Clients rely on Amplify to effectively structure contract research organization relationships and subcontracting transactions.
R&D
Whether partner R&D collaborations, CRO research or joint ventures, we protect our biotech client's interests in R&D agreements.
Life Sciences
Amplify has experience in all types of life sciences transactions - from initial research, to IP licensing to commercialization deals.
Bioinformatics
Data is changing the field of biotechnology and life sciences - Amplify can help clients navigate bioinformatics transactions.
. . . and much more.
Example Clients + Partners
Amplify attorneys have advised on critical and complicated transactions on behalf of clients with:
GSK
Pfizer
Astrazenca
Merck
Novartis
Roche
Amgen
Gilead
Boston Scientific
RTI
Quintiles
ABS
Walgreens
Medstar
McKesson
Takeda
Ohio State
NOAA
Seagate
Rhythm
Example transactions of our biotech lawyer s and life sciences practice:
Advised a health outcomes research organization on numerous research and consulting agreements for multiple Big Pharma customers including international research and multiple indications and product lines.
Represent a Silicon Valley, venture backed, biotech company in all technology and commercial transactions including sponsored research, university licensing, IP licensing and asset acquisitions, R&D and collaboration arrangements and more.
Represented a biotechnology company developing novel therapeutic products for the treatment of cardiovascular diseases, including stem cell applications, in technology transaction matters.
Advised large public pharmaceutical company on sophisticated product development efforts to diversify revenue and expand into managed services offerings based on mobile and app service delivery model.
Developed best practices licensing, services and other form agreements for a medical school and its center for health outcomes research in order to more fully protect its interests and simplify the negotiation process.
Counseled an EHR, practice management and interoperability solution provider in strategic transactions, including in-licenses of value-added products to create a broader customer solution and significantly increase marginal revenues.
